Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02861976 · ClinicalTrials.gov registry record
Screening in Trauma for Opioid Misuse Prevention
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 346
- Enrollment target
NCT02861976: Completed study, sponsored by University of Wisconsin, Madison.
NCT02861976 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 346 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02861976 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 346 participants
- Enrollment target
Study Summary
The current study seeks to begin the crucial work of creating effective protocols to prevent opioid misuse, addiction, and related complications by developing and pilot testing an opioid risk screening protocol at Wisconsin trauma centers.
Primary Outcome
This data will be analyzed in tandem with patient demographics, physical and mental health, and hypothesized risk factors for opioid misuse.
Interventions
- OTHER Opioid risk screen development & implementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2016-07-15 |
| Est. Completion | 2020-06-01 |
What the finished NCT02861976 record still lists
NCT02861976 is an observational study that tracks outcomes without assigning an intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Opioid risk screen development & implementation is the first listed.
NCT02861976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02861976 about?
NCT02861976 is a clinical study titled "Screening in Trauma for Opioid Misuse Prevention". The current study seeks to begin the crucial work of creating effective protocols to prevent opioid misuse, addiction, and related complications by developing and pilot testing an opioid risk screening protocol at Wisconsin trauma centers.
What is the current status of trial NCT02861976?
This trial is currently completed. The enrollment target is 346 participants. The study started on 2016-07-15. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT02861976?
The interventions under investigation include: Opioid risk screen development & implementation (OTHER).
Who is sponsoring clinical trial NCT02861976?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267886 · 346 participants · Phase 4
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- NCT06705842 · 346 participants · Phase 4
APPI-Cost Trial for Perforated Appendicitis
- NCT06932887 · 346 participants · Phase 3
The Beat Pain Better Trial
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI